Release Date: 23/02/21 09:56 Summary: NTA Estimate - $0.1425 Price Sensitive: No Download Document 185.43KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%